Warby Parker (WRBY) Cash from Investing Activities (2020 - 2026)
Warby Parker (WRBY) posted Cash from Investing Activities of -$16.1 million for Q1 2026, down 6.73% on a QoQ basis from -$15.1 million in Q4 2025, and little changed year-over-year from -$16.1 million in Q1 2025.
Warby Parker (WRBY) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Warby Parker's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$16.1 million for Q1 2026.
- Quarterly Cash from Investing Activities changed 0.09% year-over-year to -$16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$67.0 million (down 1.96% YoY) and the FY2025 annual result came in at -$67.0 million, down 1.54% from the prior year.
- Cash from Investing Activities was -$16.1 million for Q1 2026 at Warby Parker, down from -$15.1 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$12.2 million in Q2 2023 and bottomed at -$19.5 million in Q3 2025.
- A 5-year average of -$15.5 million and a median of -$16.1 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 84.9% — and 2023, when it rose 22.88%.
- Warby Parker's Cash from Investing Activities stood at -$14.2 million in 2022, then advanced by 4.52% to -$13.6 million in 2023, then slumped by 30.56% to -$17.7 million in 2024, then grew by 14.68% to -$15.1 million in 2025, then dropped by 6.73% to -$16.1 million in 2026.
- Business Quant data shows WRBY's Cash from Investing Activities at -$16.1 million in Q1 2026, -$15.1 million in Q4 2025, and -$19.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.15 Bn | 120.94 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.73 Bn | 43.91 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.91 Bn | 31.25 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.79 Bn | 30.55 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.52 Bn | 23.08 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.04 Bn | 13.47 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Warby Parker | 3.08 Bn | 2.79 Bn | 131.04 Mn | -16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.14 Mn |
| Mar 31, 2026 | -16.14 Mn |
| Dec 31, 2025 | -15.12 Mn |
| Dec 31, 2025 | -15.12 Mn |
| Sep 30, 2025 | -19.49 Mn |
| Sep 30, 2025 | -19.49 Mn |
| Jun 30, 2025 | -16.29 Mn |
| Jun 30, 2025 | -16.29 Mn |
| Mar 31, 2025 | -16.15 Mn |
| Mar 31, 2025 | -16.15 Mn |
| Dec 31, 2024 | -17.72 Mn |
| Dec 31, 2024 | -17.72 Mn |
| Sep 30, 2024 | -14.22 Mn |
| Sep 30, 2024 | -14.22 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Mar 31, 2024 | -16.44 Mn |
| Mar 31, 2024 | -16.44 Mn |
| Dec 31, 2023 | -13.57 Mn |
| Dec 31, 2023 | -13.57 Mn |